NCT05765578View on ClinicalTrials.gov

An Observational Study of Moderna COVID-19 Bivalent Vaccines (Original and Omicron BA.4/BA.5) and 2023 Updated mRNA COVID-19 Vaccines (XBB.1.5)

CompletedOBSERVATIONAL
Enrollment

1,713

Participants

Timeline

Start Date

March 8, 2023

Primary Completion Date

June 17, 2024

Study Completion Date

June 17, 2024

Conditions
COVID-19
Interventions
BIOLOGICAL

Moderna COVID-19 Vaccine

Sterile liquid for injection. Intervention not administered through this study.

BIOLOGICAL

Moderna mRNA1273.222 Booster

Sterile liquid for injection. Intervention not administered through this study.

BIOLOGICAL

Pfizer COVID-19 Vaccine

Sterile liquid for injection. Intervention not administered through this study.

BIOLOGICAL

Moderna 2023 Updated COVID-19 vaccine (XBB.1.5)

Sterile liquid for injection. Intervention not administered through this study.

BIOLOGICAL

Pfizer 2023 Updated COVID-19 vaccine (XBB.1.5)

Sterile liquid for injection. Intervention not administered through this study.

Trial Locations (1)

90230

Science37, Culver City

All Listed Sponsors
lead

ModernaTX, Inc.

INDUSTRY